We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
356 result(s) found, displaying 101 to 110
-
Designation or determinationOrphan drug
-
Prescription medicine registrationActive ingredients: Pneumococcal purified capsular polysaccharides.
-
Prescription medicine registrationActive ingredients: belzutifan.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Australian public assessment report (AusPar)AusPAR for Vaxneuvance (pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed) for the prevention of pneumococcal disease.
-
Designation or determinationProvisional determination
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.